Bangkok Genomics Innovation Public Company Limited stock analysis
Bangkok Genomics Innovation Public Company Limited (BKGI) Stock Price & Analysis
BKGI Stock Chart & Stats
- Day’s Range
- THB 2.00 - THB 2.16
- 52-Week Range
- THB 1.20 - THB 2.58
- Previous Close
- THB 2.30
- Volume
- N/A
- Average Volume (3M)
- 715.90K
- Market Cap
- THB 1.26B
- Enterprise Value
- THB 1.12B
- Total Cash (Recent Filing)
- THB 232.95M
- Total Debt (Recent Filing)
- THB 19.08M
- Price to Earnings (P/E)
- 13.3
- Beta
- 1.30
- Next Earnings
- Mar 03, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- May 06, 2026
- Dividend Yield
- 2.38%
BKGI FAQ
What was Bangkok Genomics Innovation Public Company Limited’s price range in the past 12 months?
What is Bangkok Genomics Innovation Public Company Limited’s market cap?
When is Bangkok Genomics Innovation Public Company Limited’s upcoming earnings report date?
How were Bangkok Genomics Innovation Public Company Limited’s earnings last quarter?
Is Bangkok Genomics Innovation Public Company Limited overvalued?
Does Bangkok Genomics Innovation Public Company Limited pay dividends?
What is Bangkok Genomics Innovation Public Company Limited’s EPS estimate?
How many shares outstanding does Bangkok Genomics Innovation Public Company Limited have?
What happened to Bangkok Genomics Innovation Public Company Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Bangkok Genomics Innovation Public Company Limited?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Bangkok Genomics Innovation Public Company Limited
Bangkok Genomics Innovation Public Company Limited, trading as BKGI.BK, is a Thailand-based enterprise delivering a diverse array of clinical and genomic services. Their core genetic offerings include the NIFTY brand for non-invasive prenatal testing, screening for fetal chromosomal abnormalities, and the VISTA brand, which provides genetic disease carrier screening for applications such as pre-embryo implantation, general carrier status, and the detection of gene anomalies linked to thalassemia anemia. Additionally, they offer HPV DNA testing, colon cancer screening under the COLOTECH brand, and personalized genetic analyses through the DNALL brand. Beyond genetic diagnostics, the company provides comprehensive testing for infectious diseases, including real-time PCR, antigen, serology, and neutralizing antibody assays for COVID-19, alongside real-time PCR testing for the monkeypox virus. Their technology solutions segment covers advanced services like DNA and RNA base sequencing, as well as metabolism and protein omics tests. The company also acts as a distributor for essential medical supplies, such as PCR COVID-19 test kits, personal protective equipment (PPE), and vital transport media. BKGI's broader service portfolio encompasses health analytics, medical care, and the development of biotechnology products. They also offer cell advanced therapy medicinal products and provide consulting services for small businesses. Furthermore, the company operates an education center, engages in research activities, and is involved in the retail sale of pharmaceutical products. Remarkably, their operations extend into other sectors, including the provision of heavy machinery such like hydraulic excavators, tractors, wheel-loaded air compressors, and their spare parts, in addition to real estate development. Founded in 2017, Bangkok Genomics Innovation Public Company Limited is headquartered in Bangkok, Thailand.
- Sector
- General
- Industry
- Medical - Diagnostics & Research
- CEO
- Saowalak Dansakul
- Employees
- 37
- Website
- www.bangkokgenomics.com
- Address
- 3689 Rama 4 Road, Bangkok, BM, 10110, TH
Bangkok Genomics Innovation Public Company Limited (BKGI) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 2 | 12 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 2 | 0 | 10 |

